Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2210]

Fast-tracked cancer drug candidate causes substantial levels of mutations and must be investigated for risk of secondary cancer

Fast-tracked cancer drug candidate causes substantial levels of mutations and must be investigated for risk of...

Environment and wallet benefit from redispensing cancer pills

Environment and wallet benefit from redispensing cancer pills

FDA approves enzalutamide for non-metastatic castration-sensitive prostate cancer with biochemical recurrence

FDA approves enzalutamide for non-metastatic castration-sensitive prostate cancer with biochemical recurrence

MEPs face an immediate choice with implications that reach ahead for decades: the real issue underlying safeguards for genomic data-sharing

MEPs face an immediate choice with implications that reach ahead for decades: the real issue underlying safeguards...

War and prejudice: the problems faced by patients with advanced breast cancer in accessing appropriate treatments

War and prejudice: the problems faced by patients with advanced breast cancer in accessing appropriate treatments

Targeted treatment for advanced breast cancer including CDK4/6 inhibitor therapy reaches patients in Mozambique for the first time

Targeted treatment for advanced breast cancer including CDK4/6 inhibitor therapy reaches patients in Mozambique...

FDA amends pembrolizumab’s gastric cancer indication

FDA amends pembrolizumab’s gastric cancer indication

FDA approves pembrolizumab with chemotherapy for biliary tract cancer

FDA approves pembrolizumab with chemotherapy for biliary tract cancer

FDA approves toripalimab-tpzi for nasopharyngeal carcinoma

FDA approves toripalimab-tpzi for nasopharyngeal carcinoma

FDA approves ivosidenib for myelodysplastic syndromes

FDA approves ivosidenib for myelodysplastic syndromes

More from ecancer